An inter-machine comparison of tobacco smoke particle deposition in vitro from six independent smoke exposure systems  by Adamson, J. et al.
Toxicology in Vitro 28 (2014) 1320–1328Contents lists available at ScienceDirect
Toxicology in Vitro
journal homepage: www.elsevier .com/locate / toxinvi tAn inter-machine comparison of tobacco smoke particle deposition
in vitro from six independent smoke exposure systemshttp://dx.doi.org/10.1016/j.tiv.2014.06.012
0887-2333/ 2014 The Authors. Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Abbreviations: ALI, air–liquid interface; ANOVA, analysis of variance; ISO,
International Organisation for Standardisation; QC, quality control; QCM, quartz
crystal microbalance; R&r, reproducibility (R) and repeatability (r); SD, standard
deviation; VC 10, Vitrocell VC 10 Smoking Robot; WHO, World Health
Organisation.
⇑ Corresponding author. Tel.: +44 02380 588220; fax: +44 02380 588856.
E-mail addresses: jason_adamson@bat.com (J. Adamson), david_thorne@bat.com
(D. Thorne), graham_errington@bat.com (G. Errington), FIELDSW@RJRT.com (W.
Fields), lixiang79ben@hotmail.com (X. Li), Rebecca.payne@covance.com (R. Payne),
t.krebs@vitrocell.com (T. Krebs), annette_dalrymple@bat.com (A. Dalrymple),
FOWLERK2@RJRT.com (K. Fowler), debbie_dillon@bat.com (D. Dillon), xiefuwei@
sina.com (F. Xie), clive_meredith@bat.com (C. Meredith).J. Adamson a,⇑, D. Thorne a, G. Errington a, W. Fields b, X. Li c, R. Payne d, T. Krebs e, A. Dalrymple a
K. Fowler b, D. Dillon a, F. Xie c, C. Meredith a
aBritish American Tobacco, Group R&D, Southampton SO15 8TL, UK
bR.J. Reynolds Tobacco Co., P.O. Box 1487, Winston-Salem, NC 27102, USA
c Zhengzhou Tobacco Research Institute of China National Tobacco Corporation, No.2 Fengyang Street, High-Tech Zone, Zhengzhou, PR China
dCovance Laboratories Ltd., Otley Road, Harrogate HG3 1PY, UK
eVitrocell Systems GmbH, Fabrik Sonntag 3, 79183 Waldkirch, Germany
a r t i c l e i n f oArticle history:
Received 3 April 2014
Accepted 23 June 2014






In vitro exposure system
Vitrocella b s t r a c t
There are several whole smoke exposure systems used to assess the biological and toxicological impact of
tobacco smoke in vitro. One such system is the Vitrocell VC 10 Smoking Robot and exposure module.
Using quartz crystal microbalances (QCMs) installed into the module, we were able to assess tobacco
smoke particle deposition in real-time. We compared regional deposition across the module positions
and doses delivered by six VC 10s in four independent laboratories: two in the UK, one in Germany
and one in China.
Gauge R&r analysis was applied to the total data package from the six VC 10s. As a percentage of the
total, reproducibility (between all six VC 10s) and repeatability (error within an individual VC 10)
accounted for 0.3% and 7.4% respectively. Thus Gauge R&r was 7.7%, less than 10% overall and considered
statistically ﬁt for purpose.
The dose–responses obtained from the six machines across the four different locations demonstrated
excellent agreement. There were little to no positional differences across the module at all airﬂows as
determined by ANOVA (except for one machine and at three airﬂows only). These results support the
on-going characterisation of the VC 10 exposure system and suitability for tobacco smoke exposure
in vitro.
 2014 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Background
Tobacco smoke generated by machine smoking is commonly
used for tobacco product assessment in vitro, for modelling disease
processes and for toxicological assessment. The World Health
Organisation (WHO) upholds that machine testing of combustibletobacco products cannot accurately estimate human exposure,
and should not be used to support claims of reduced exposure or
risk (World Health Organisation, 2007). However, the WHO does
support the use of machine smoke emission data for product haz-
ard assessment, to characterise cigarette emissions for product
design and regulatory purposes (World Health Organisation, 2007).
Smoking machines generate, dilute and deliver mainstream
tobacco smoke (also known as whole smoke) to an exposure cham-
ber/module containing a biological system, usually supported at
the air–liquid interface (ALI). There are many types of smoking
machines and exposure chambers available for the testing of whole
smoke at the ALI. Some are small bespoke laboratory set-ups
whereas others are commercially available systems utilised by
the tobacco industry and other well-known inhalation toxicology
research groups (Thorne and Adamson, 2013). Whichever system
is utilised, there is a clear need to characterise the capabilities, lim-
itations, dilution principles, smoke losses and exact dose delivery
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obtained from smoke exposures. In addition, good understanding
and characterisation of the machine, and ultimately full validation,
should facilitate the endorsement of the machine for the genera-
tion of biological data.
Method validation is the process of demonstrating that an ana-
lytical method is suitable for its intended use, and involves con-
ducting a variety of studies to evaluate method performance
under deﬁned criteria (Thompson et al., 1999). Method validation
studies may involve a single laboratory (intra-laboratory) or multi-
ple laboratories (inter-laboratory). Organisations such as the Asso-
ciation of Analytical Communities (AOAC) and US Environmental
Protection Agency (EPA) provide methods that are validated
through inter-laboratory studies, and parameters which may be
assessed in method validation include precision deﬁned by repro-
ducibility (R) and repeatability (r) and bias (Ellison et al., 2009).
Thus, inter-laboratory studies/cross-machine comparisons enable
conﬁdence to be gained in a machine or laboratory set-up and
can facilitate the standardisation of experimental testing protocols.
As such, data generated from method validation studies or stand-
ardised protocols could provide information for future regulation
or testing standards.
Currently, there are no deﬁned regulatory protocols for tobacco
whole smoke exposure systems, but product testing protocols for
assays such as Ames bacterial mutagenicity and Neutral Red
Uptake (NRU) cytotoxicity are being developed to support in vitro
toxicity testing and disease model development. One such smoking
machine/exposure system used for the testing of tobacco whole
smoke is the Vitrocell VC 10 Smoking Robot and mammalian
exposure module (Vitrocell 6 CF Stainless) both of which have
been previously described (Adamson et al., 2013; Klein et al.,
2013; Nara et al., 2013; Okuwa et al., 2010). Additionally, quartz
crystal microbalance (QCM) technology can be employed to accu-
rately assess deposited particle mass within the exposure module.
QCMs enable a greater understanding of particle dose as mass per
surface area, rather than simply a diluting airﬂow and sampling
vacuum ﬂow rate applied to the exposure module (Adamson
et al., 2013; Paur et al., 2011; Bakand and Hayes, 2010; Lenz
et al., 2009). To assess deposition, QCMs are installed in the expo-
sure module in place of the biological system, giving real-time,
in situ gravimetric data on particle deposition, in the nanogram
range (Fig. 1).Fig. 1. A schematic cross-section of the Vitrocell exposure system set-up (not to scale).
the dilution bar; (b) smoke entry (dark arrow) to a single dilution bar where diluting air
dilution bar has one smoke jet (ci) which is always 2.0 mm ; (in this study), and 2 identi
both 0.8 mm ;, depending on dilution airﬂow; and (d) mammalian 6/4 CF Stainless expos
from Adamson et al. (2013).In this study, six Vitrocell VC 10 Smoking Robots were
assessed for their ability to generate a consistent smoke dose, using
QCMs to quantify deposited particle matter within the exposure
module (Fig. 1d). The QCMs took readings from each position in
the module, the ﬁrst position being proximal to smoke entering
the dilution bar, the last position being distal to smoke entry
(Fig. 1b). It is important to consider this arrangement, as in some
instances the linear direction of smoke entry may have an effect
on regional/positional deposition differences across the QCMs left
to right (Deschl et al., 2011). The aim of this study was to enable
the comparison of multiple VC 10s, in four independent laborato-
ries/geographical locations, tested with an identical diluting air-
ﬂow range of 0.25, 0.5, 1.0, 2.0 and 4.0 L/min. These airﬂows
were selected for testing based on a previously published study
(Adamson et al., 2013) which represented reliably detectable levels
for the QCMs during a 24 min exposure. To preserve anonymity of
machine, lab, group and operator, all were coded (Table 1.) as is
common practice for comparison studies. The six VC 10s were
located in four laboratories: two laboratories were in the United
Kingdom, one was in China and one was in Germany. Regional
deposition patterns across the exposure module were assessed
independently at each airﬂow for each machine. R&r analysis was
estimated for all six instruments which were collectively termed
the ‘measurement system’. R&r analysis determines the precision
of a measurement system and is often employed to compare multi-
ple systems in different locations or with different operators; more
speciﬁcally it calculates the degree to which repeated measure-
ments taken under the same (unchanged) experimental conditions
show the same result (Measurement Systems Analysis reference
manual, 2002). Reproducibility (R) is the closeness of agreement
between measurements or observations conducted on replicate
specimens (machines) in different locations by different people;
it assesses the ability of the experiment or measurement to be
reproduced independently. Repeatability (r) looks at test–retest
variability; it assesses the variation in measurements made within
the same system by the same operator (Kaur et al., 2010). Thus,
data were compared within each machine and across all six
machines. Additionally, two important variables were assessed
by comparing data from VC 10s which had a signiﬁcant change.
The ﬁrst was laboratory geography/environment, where data were
acquired on the same VC 10 (serial VC 10/300412) in two different
laboratories after it was moved from one to another. The second(a) VC 10 Smoking Robot including the single piston/syringe and delivery tubing to
is added (white arrows). Multiple parallel bars make the dilution system; (c) each
cal air jets above and below the dilution bar (cii) which are either both 1.0 mm ; or
ure module with QCMs installed into each of the four separate wells. Image adapted
Table 1
The VC 10s used in this study, serial number identiﬁer, laboratory location and their
operators.
VC 10 name Serial number Laboratory Operator(s)
A1 VC 10/141209 A a
B1 VC 10/090610 B b, c, d
B2 VC 10/221211 B b, c, d, e
B3 VC 10/210311 B c, e
C1 VC 10/300412 C a
D1 VC 10/200410 D a, f
1322 J. Adamson et al. / Toxicology in Vitro 28 (2014) 1320–1328was service status of the machine, where data were acquired on
the same VC 10 (serial VC 10/141209) in the same location before
and after an annual service (which was 6 month overdue), and the
results compared.Table 2
Smoking settings used for the VC 10 on all machines. For machines A1 and C1, diluting
airﬂows were set and maintained during the duration of the experiment by mass ﬂow
controllers (Analyt-MTC GmbH, Mülheim, Germany); for machines B1–B3 and D1,
diluting airﬂows were set manually with valves integral to the Vitrocell dilution
system and checked using a mass ﬂow meter prior to each run.
Machine parameters User input
Inhale Curve Numbera 1
Piston size (ml) 100
Puff duration time (s) 2
Puff duration hold time (s) 0
Puff duration exhaust time (s) 8
Puff volume (ml) 35
Puff frequency (s) 60
Number of clear cycles after run 0
Max. number of inhalation cycles per cigarette 8
Number of cigarettes per run 3
a Inhale Curve Number 1 represents a bell-shaped pufﬁng proﬁle.2. Materials and methods
2.1. Machine smoking
Six independent but comparable VC 10 Smoking Robots (Vitro-
cell Systems, Waldkirch, Germany) (Fig. 1) were tested. The six
machines were located across four laboratories in Southampton,
UK; Harrogate, UK; Zhengzhou, China; and Waldkirch, Germany.
For anonymity, each machine was given a coded name based on
its location (Table 1). Apart from machines B3 and D1, all VC 10s
had a 4-port dilution bar with an exposure module (model 6/4
CF Stainless) (Vitrocell Systems) containing 4 QCMs docked
within it to detect deposited particle mass, as shown in Fig. 1.
The dilution bars of machines B3 and D1 were the shorter variant
with three instead of four smoke ports. Therefore, the module used
with VC 10 B3 and D1 was the 6/3 CF Stainless and contained 3
QCMs for measurements taken in positions 1–3. Both the 3 and
4-port dilution bars and their respective modules are commercially
available. Consequently, equipment and experimental variables
were comparable across the four laboratories/six machines, includ-
ing smoke transit tubing lengths to the dilution bar (34–45 cm)
and module trumpet heights (of approximately 2 mm from the
QCM surface), as per manufacturer’s speciﬁcations. In this study,
laboratories A, B and D had controlled environmental conditions
where temperature and humidity were set and maintained at
20 ± 5 C and 55 ± 15% relative humidity. The VC 10 in laboratory
C was placed inside an open cabinet, sat within a test room with
uncontrolled environmental conditions. Data generation for an
individual machine took between two and six (nonconsecutive)
days; all six machines were assessed and data collected between
July 2012 and July 2013. The main reason that multiple machines
were not tested in parallel was feasibility; there were limited
QCM devices to make parallel geographic investigations.
The generation, dilution and delivery of whole smoke to biolog-
ical systems by the VC 10 has been previously described (Adamson
et al., 2013). Cigarette smoke can be delivered by three operational
modes (single, serial-asynchronous and serial-synchronous) with the
VC 10 as detailed by the manufacturer (Vitrocell Systems, Wald-
kirch, Germany). For the purposes of this study, cigarette smoke
was generated via the rotary carousel, where one cigarette is
loaded and smoked at a time (VC 10 single mode). A single syringe
located under the rotary carousel puffs on the cigarette to the ISO
3308:2000 smoking regime: 35 ml puff over 2 s, once a minute.
Although not representative of human smoking behaviour, the
ISO smoking regime was selected as an industry standard, allowing
cross-comparisons of different machines with the same regime,
cigarette and dilution range. Three reference cigarettes (3R4F,
9.4 mg tar) obtained from the University of Kentucky, USA, were
smoked to a deﬁned puff number of 8 puffs per cigarette, resultingin 24 min duration per run. In all cases, the same dilution bar and
module containing the QCMs were used for all airﬂows tested on
an individual VC 10. In the dilution bar of all machines and at all
airﬂows the 2.0 mm£ smoke jet was installed (Fig. 1ci). For
machines A1, C1 and D1, two 1.0 mm£ diluting air jets were
installed for all airﬂows tested (Fig. 1cii). For the B machines the
two diluting air jets were both 0.8 mm£ for 0.25 and 0.5 L/min
airﬂows only (the other airﬂows P1.0 L/min had the 1.0 mm£
diluting air jets), as per the supplier’s original recommendations.
However, full comparison studies of the jet combinations in labo-
ratories A and D showed there were no statistically signiﬁcant dif-
ferences in particle dose determined by QCMs when using the
2.0 mm£ smoke jet and 1.0 mm£ airﬂow jets combination for
airﬂows less than 1 L/min (p = 0.961 as determined by one-way
ANOVA (at 0.5 L/min in laboratory D, n = 5/QCM position/jet com-
bination)). Thus for experimental simplicity, the same smoke and
air jet combination (2.0 mm£ and 1.0 mm£ respectively) were
maintained for all airﬂows for VC 10 A1, C1 and D1. Five airﬂows
(0.25, 0.5, 1.0, 2.0 and 4.0 L/min) were tested and smoke dilutions
were obtained by adjusting the airﬂow delivered to the dilution
system. All other programmed smoking settings for the smoke
run were the same across the six machines and are described in
Table 2.2.2. Dosimetry measurements
For real-time assessment of deposited particle dose in machines
A1, B1, B2 and C1, four identical quartz crystal microbalance (QCM)
units were installed into each separate well of the 6/4 CF Stainless
exposure module (Fig. 1d) (Adamson et al., 2013). As previously
described, machines B3 and D1 were equipped with the 3-port
dilution bar and 6/3 CF Stainless exposure module, therefore three
QCMs were installed to assess smoke particle deposition. QCMs
were not reordered between runs but always kept in the same
positions for the entirety of each study. In previous investigations,
we have discovered that randomising QCMs in the module does
not affect dose in that speciﬁc position. Additionally, measurement
stability and repeatability is greatly improved when the QCM
housing units are left and not constantly removed and replaced
(although the crystal surfaces are still cleaned in situ, between each
run). Individual seals between lid and base for each QCM position
were not leak tested prior to each exposure. Smoke leakage could
be a possible cause for deposition variability; however, it would
be unlikely that large smoke leakage was occurring as such an
event would have been detected (visual and odor) by the opera-
tor(s). Exposure module seal integrity and leak testing is conducted
as part of the service agreement, but VC 10 users should also be
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tion bar (Fig. 1b) smoke was sampled from the stream of diluted
smoke at a ﬂow rate of 5 ml/min/well negative pressure through
the module, as previously described (Adamson et al., 2013).
QCM units and software were supplied by Vitrocell Systems.
The QCMs read at a resolution of 10 ng/cm2/s; mass readings were
taken every 2 s during the smoke run and reported as mass per unit
area in real-time (Mülhopt et al., 2009). In terms of their limit of
quantiﬁcation, QCMs have been shown to be able to detect particle
mass in the nanogram range delivered from low tar delivery prod-
ucts (1 mg) at high dilutions (Adamson et al., 2012), and in the case
of the VC 10 with 3R4F reference cigarettes, at very high diluting
airﬂow rates up to 12 L/min (Thorne et al., 2013). In this study dur-
ing data collection, QCMs were stabilised prior to exposure (zero
point stability) and were allowed to plateau post-smoke particle
deposition, until the mass had stopped increasing. This took an
additional 60–120 s post-exposure and represented the maximal
particle deposition recorded for the set airﬂow.
2.3. Graphics and statistics
For all six machines, experiments were repeated 5 times per air-
ﬂow. Figs. 2–6 were produced using Minitab version 16.1.0. The
means of deposited mass ± standard deviation (Table 3) were cal-
culated from the raw data in Microsoft Excel 2010. Differences
in regional deposition across/between module positions (Figs. 3
and 6, and Table 4.) were determined by one-way analysis of var-
iance (ANOVA) with Tukey method using Minitab. Statistical tests
for R&r (Table 5) were conducted using JMP Pro version 10 and
Minitab. Evaluating the Measurement Process (EMP) Gauge R&r
was conducted in JMP Pro version 10 as described by Wheeler
(2006).3. Results
The data generated from each VC 10 were analysed within itself
(intra-machine) to assess regional deposition at the airﬂows tested,
and analyses were made between VC 10s (inter-machine) at the
same airﬂows and collectively in the diluting range 0.25–4.0 L/
min (inter-laboratory). Fig. 2 and Table 3. illustrate the deposited
particle dose–response relationship for each machine at airﬂows
0.25–4.0 L/min, demonstrating good parity between the six VC
10s. In addition, Fig. 3 details the pattern of particle deposition
across the module positions based on a data set of n = 5/QCM posi-
tion/airﬂow/machine. From the data presented in Fig. 3, it is clear
to see varied deposition patterns across QCM positions at the lower
airﬂows 0.25 and 0.50 L/min compared to the higher airﬂows 1.0,
2.0, 4.0 L/min. Furthermore, despite the machines being the sameFig. 2. QCM particle deposition: an interaction plot of the data means for the six VC
10s within the airﬂow range tested.model there are some differences in the varied distribution
between VC 10s at the same airﬂows. For example, machine C1
shows a distinct distribution of deposition at the highest concen-
tration of 0.25 L/min, where deposition ascends between positions
1–3 and then drops at position 4. For other machines, there is a
total ascending gradient from ﬁrst to last QCM position, such as
machine B2 at 0.25 L/min or C1 at 0.50 L/min. In other cases, there
are ‘zigzagged’ distributions where deposition ascends and des-
cends between QCM positions, such as machine B1 at 0.25 L/min.
Particle deposition distribution across the modules for ﬁve of
the six machines (all but VC 10 C1) had good agreement at all air-
ﬂows, as there were no signiﬁcant differences observed across the
QCM positions as determined by one-way ANOVA (Table 4). There
were signiﬁcant differences across QCM positions for three of the
ﬁve airﬂows on VC 10 C1.
In order to visualise the overall pattern of distribution across
the QCM positions from each VC 10, multi-vari charts were pro-
duced to display the mean particle distribution at all airﬂows
tested per machine (Fig. 4). For the complete airﬂow range tested
(Fig. 4a), machine C1 demonstrated a very distinct pattern of par-
ticle deposition across the positions left to right, where mass
ascended signiﬁcantly from positions 1–3 and dropped at position
4. As indicated by the diamonds (the mean of the four QCM posi-
tions), machine C1 delivered the highest dose of the six machines.
The B machines also showed slight variation in their patterns of
distribution. However, the overall means, as indicated by the dia-
monds, were more consistent between the three B machines and
machine D1. Machine A1 had the lowest mean delivery of all.
The mean pattern of particle deposition when 0.25 L/min is
excluded (as recommended by the supplier due to inherent limita-
tions of low ﬂow turbulence and inefﬁcient mixing in the short
transit length available) resulting in a range of 0.5–4.0 L/min was
also assessed (Fig. 4b). The variation between QCM positions
improved for every VC 10 and a more linear pattern was observed
across all positions. The data means across the machines also
showed more alignment in this range, as indicated by the proxim-
ity of the diamonds (Fig. 4b).
Evaluating the Measurement Process (EMP) Gauge R&R (Wheeler,
2006) was applied to the total data package, which is the data from
all QCM positions at all airﬂows for all machines. As a percentage of
the total, reproducibility (error between all six VC 10s) and repeat-
ability (error within an individual VC 10) accounted for 0.3% and
7.4% respectively, the inter-machine variability (reproducibility)
being especially low. Thus, total R&r was 7.7%; less than 10% over-
all and considered statistically ﬁt for purpose (Barrentine, 1991).
As expected, by the nature of the dilution process giving the differ-
ent smoke doses, the main product variation in this evaluation was
from airﬂow at 90.4%. The interaction variation of VC 10 and air-
ﬂow was also low at 1.9%. Table 5 shows the R&r values for the
individual airﬂows tested and the mean mass per airﬂow for all
six machines. Values for reproducibility and repeatability decrease
with a reduction in mean mass/increase in diluting airﬂow. Only
reproducibility (R) at 0.25 L/min was greater than 10%. The R value
for 0.25 L/min (20.30%) indicates poor inter-laboratory precision at
this airﬂow, which conﬁrms the supplier’s recommendation not to
operate at airﬂows less than 0.5 L/min (or at least to use with cau-
tion). However, within any individual VC 10, intra-machine vari-
ability (r) at 0.25 L/min was 7.71 which would be considered
perfectly acceptable.
Main effects plots were used to assess variables associated with
the inter-machine study: the individual machines (VC 10), labora-
tory and QCM position. Fig. 5a and b shows the data means for
machine and lab respectively. Machine C1 in lab C delivered higher
particle doses overall. Fig. 5c shows the data means for QCM posi-
tion for all machines at all airﬂows and would suggest that within
the dilution bar of any VC 10 there is a tendency for the mass to
Fig. 3. A multi-vari chart for deposited particulate mass, showing deposition gradients across the module for all airﬂows tested. The connected black dots represent QCM
positions, left to right. Data sets were n = 5/QCM position/airﬂow/machine. Asterisks indicate statistically signiﬁcant differences in deposition across/between module
positions as determined by one-way ANOVA. Diamonds detail the mean deposited particle mass detected at each airﬂow. Circles indicate the total mean deposited mass for
an individual VC 10 at all airﬂows tested, and are connected by a dashed line to show the relationship between machines.
Fig. 4. Multi-vari charts showing mean deposited particulate mass for the six VC 10 machines. The chart shows the mean deposition gradient across the module positions (1–
4 or 1–3) for (a) the complete range of airﬂows tested within each machine 0.25–4.0 L/min, and (b) the supplier recommended working range of 0.5–4.0 L/min (excluding
0.25 L/min data). The diamonds indicate the overall mean deposited particle mass detected for all QCM positions at the airﬂows tested, the dashed line showing the
relationship between machines.
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tion 3–4 (distal to smoke entry).
In addition to the variables associated with the inter-machine
study (Fig. 5), two other conditional and important VC 10 variables
were assessed. The variables were laboratory environment and ser-
vice status (maintenance) of the machine. Fig. 6a shows how mov-
ing a VC 10 from one lab to another affected smoke delivery
(deposition). As previously shown, VC 10 C1 demonstrated the
most varied patterns of deposition across the module, especially
at airﬂows 0.25, 0.5 and 2.0 L/min where there were statistically
signiﬁcant differences (Fig. 3). Consequently, when machine C1
was relocated to laboratory B and the data generation were repli-
cated, the results were compared to the range from machines
B1–B3 (shown in the light grey boxplots) (Fig. 6a). Not only did
the data obtained with machine C1 in Lab B align with the other
machines in the same location, but also there were no signiﬁcantdifferences between module positions observed – demonstrating
a signiﬁcant improvement. This could be due to laboratory condi-
tions (where laboratory B had stable environmental conditions
whereas laboratory C did not), or it may also have been due to a
machine service prior to installation in laboratory B. A similar
result was demonstrated on machine A1 when data were captured
pre- and post-service (Fig. 6b). In this case, other than service sta-
tus and date of the experiment, the location and set-up were the
same. Pre-service, machine A1 gave extremely varied results
(Adamson et al., 2013), conﬁrmed by signiﬁcant differences
between QCM positions at all airﬂows tested (Fig. 6b). However,
in the days directly after a 6 month overdue service (in which
machine A1 was dismantled, cleaned and reassembled) the results
obtained were fully aligned with the VC 10 data from the other lab-
oratories, and deposition positional effects had improved signiﬁ-
cantly. Both of these circumstances (environment and machine
Fig. 5. A main effects plot for deposited mass. The charts show the data means for (a) the six different VC 10 machines; (b) the four different laboratories where the testing
was conducted, and; (c) QCM positions (1–4, or 1–3 for B3 and D1). Mean reference line for each chart is 4.67 lg/cm2.
Fig. 6. Variables affecting smoke particle deposition. Multi-vari charts showing (a) the effect of geographical location/laboratory environment on the same VC 10, and (b)
smoke particle deposition before and after VC 10 service. (a) VC 10 C1 was moved from laboratory C to laboratory B; the grey boxplots show the means of the deposition from
machines B1–B3 putting VC 10 C1 data (black dots) into context of the B lab machines. (b) Data from machine A1 is shown pre- (June 2012) (Adamson et al., 2013) and post-
service (July 2013). Data sets were n = 5/QCM position/airﬂow/machine. Asterisks indicate statistically signiﬁcant differences in deposition across/between module positions
as determined by one-way ANOVA.
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of the VC 10, and will be discussed later.
4. Discussion
There are a variety of smoking machines used for the assess-
ment of tobacco smoke in vitro. The system described in this studyis the commercially available Vitrocell VC 10 Smoking Robot
which dilutes smoke with continuous airﬂow at adjusted rates to
obtain different smoke concentrations. Before the advent of parti-
cle dosimetry tools such as the QCM, there was no quick or simple
way of measuring dose/exposure, and especially not with the abil-
ity to observe it in real-time and with the sensitivity the QCM
delivers. Furthermore, biological response (from any in vitro sys-
Table 3
Mean deposited particulate mass values obtained from the QCM (± standard deviation) for the six machines at all airﬂows tested. Data sets were n = 5/QCM position/airﬂow/
machine; all machines except B3 and D1 had 4 QCM positions for each airﬂow tested (n = 20) whereas VC 10 B3 and D1 had 3 QCM positions for each airﬂow tested (n = 15).
Airﬂow, L/min Mean deposited mass, lg/cm2 ± SD
0.25 0.50 1.00 2.00 4.00
VC 10 A1 10.15 ± 1.72 5.22 ± 0.50 3.23 ± 0.37 1.33 ± 0.22 0.41 ± 0.06
VC 10 B1 10.16 ± 1.02 6.24 ± 0.46 3.88 ± 0.21 1.79 ± 0.12 0.70 ± 0.12
VC 10 B2 12.58 ± 2.68 6.24 ± 0.62 3.35 ± 0.34 1.24 ± 0.20 0.46 ± 0.13
VC 10 B3 11.93 ± 3.42 6.02 ± 0.30 3.60 ± 0.27 1.82 ± 0.12 0.66 ± 0.07
VC 10 C1 14.08 ± 4.55 7.11 ± 1.32 3.52 ± 0.55 1.36 ± 0.24 0.40 ± 0.08
VC 10 D1 11.64 ± 1.15 5.73 ± 0.54 3.16 ± 0.18 1.63 ± 0.11 0.58 ± 0.10
Table 4
Level of statistically signiﬁcant difference across positions (1–4, or 1–3 for B3 and D1)
for all machines at all airﬂows tested (n = 5/QCM position/airﬂow/machine) as
determined by one-way ANOVA.
Airﬂow, L/min p-Value
0.25 0.50 1.00 2.00 4.00
VC 10 A1 0.353 0.611 0.865 0.994 0.418
VC 10 B1 0.507 0.284 0.431 0.802 0.979
VC 10 B2 0.330 0.418 0.646 0.967 0.916
VC 10 B3 0.829 0.335 0.178 0.360 0.868
VC 10 C1 0.012* 0.038* 0.244 0.013* 0.189
VC 10 D1 0.345 0.184 0.535 0.364 0.820
* Statistically signiﬁcant difference between positions, p = 60.05.
Table 5
Mean mass and reproducibility and repeatability (R&r) results for the measurement
system (all six VC 10s).
Airﬂow, L/min Mean mass, lg/cm2 Reproducibility, R Repeatability, r
0.25 11.75 20.30 7.71
0.50 6.11 8.05 2.03
1.00 3.46 3.24 0.99
2.00 1.51 3.06 0.51
4.00 0.53 1.61 0.27
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dilution and test article delivery mechanism. QCMs when used
concurrently with a biological assay enable biological response to
be presented as deposited particle mass per surface area. As dem-
onstrated herein, data from QCMs or other dosimetry tools will
facilitate cross-comparisons between different systems (where
the systems use the same/similar dosimetry tools).
In this study, six VC 10 Smoking Robots in four different loca-
tions were assessed using QCMs with the aim of conducting a
method validation study involving multiple laboratories. Depos-
ited particle mass was monitored in real-time and the ﬁnal depos-
ited mass recorded, regional deposition was assessed and dose
comparisons were made within and between machines. Five air-
ﬂows were selected for testing based on a previously published
study (Adamson et al., 2013) which represented reliably detectable
levels for the QCMs during a 24 min exposure. For all airﬂows a
sample rate of 5 ml/min/well negative pressure was applied to
the module. The selected airﬂows represent low to mid-range
(0.25–4.0 L/min) airﬂows of which the VC 10 is capable of operat-
ing; however, this range does not delimit the working range of the
VC 10 for biological exposure or the ability of the QCMs to detect
mass. Indeed, the VC 10 and QCM technology is used at airﬂows
up to 12 L/min with the Neutral Red Uptake assay (NRU) and Ames
assay (Thorne et al., 2013), and any positional differences observed
in QCM deposition across the module have not been reﬂected in
the biological response. Fig. 4b showed the improvement in the
consistency of dose delivery in the module when the 0.25 L/min
data were removed from the rest of the airﬂows tested; this isbecause 0.5 L/min is stated as the lower limit of recommended
working range, whereas 0.25 L/min is out of the (supplier) recom-
mended working range due to low mixing ﬂow/low turbulence.
Thus the variances in dose delivery from ﬂows less than 0.5 L/
min can be explained by less turbulence and insufﬁcient transit
length/time for the whole smoke aerosol to achieve homogeneity
prior to exposure. The Gauge R&r results from this study conﬁrmed
this with an R value of 20.30% for the 0.25 L/min airﬂow, indicating
that inter-laboratory precision at 0.25 L/min is poor (amongst
these six VC 10s).
All deposition measurements within a module were made from
four QCM readings apart from machines B3 and D1 which had
three QCM readings. The variables which changed were operator,
the date when the data were collected and the dilution bar air
jet diameter (for airﬂows 60.5 L/min). There was agreement in
dose response relationship across the six VC 10s (Fig. 2); however,
the distribution across the module positions (left–right) was irreg-
ular across certain VC 10 systems and airﬂows (Figs. 3 and 4). Nota-
bly, machine C1 was slightly separate from the other ﬁve machines
when analysed statistically. However, when evaluating these
results, other factors that could inﬂuence the variability must be
considered. For example, the deposition data range/distribution
may shift or change depending on how often the machine is used,
its service status and most importantly its cleanliness (Fig. 6b).
This has been demonstrated in this study where the data genera-
tion for machines commencing directly after a full machine service
resulted in highly repeatable results per airﬂow. The service of the
VC 10 provided by Vitrocell (either annual or biannual, dependent
on usage and user preference) consists of stripping down the
machine to its component parts, a thorough cleaning of everything,
and replacement of all dispensable parts such as labyrinths, O-
rings, seals, ﬁlters and tubing. The service also involves an exten-
sive checking (and re-calibration if out of speciﬁcation) of param-
eters such as puff volume and duration, carousel turning time
and speed, cigarette loading, lighting and removal.
With any laboratory equipment there is a requirement over its
period of use to ensure that the apparatus/machinery is still func-
tioning to manufacturers’ speciﬁcation, that it performs correctly
and that results are consistent over time, especially if its use results
in the machine requiring cleaning/maintenance. Of the VC 10s
assessed in this study, many users have noted/observed slight
changes in machine performance and delivery over time, namely
with smoke dose, mixing and deposition. Control charts for the
data obtained on machine A1 have also conﬁrmed change over
time. Fig. 6b clearly shows a marked improvement in smoke parti-
cle deposition post-service, not only with the range of doses per
airﬂow aligning with the other VC 10s, but also an improvement
in the pattern of deposition across the module positions where
no positional differences were observed post-service. It should also
be noted that the annual service was overdue at 18 months as
opposed to 12 months at that time (and which is now scheduled
every 6 months). In support of this, the data from machine D1
was also acquired directly after service and the standard deviation
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VC 10s (Table 3). Accordingly, the other machines in the study
were all within their annual service period, although the data were
not generated directly after their service. Thus, we have observed
in two separate instances how data acquisition in close proximity
to machine service has delivered more robust results. This observa-
tion will clearly be of beneﬁt to Vitrocell users, who should be
aware of the impact the frequency of use has on machine perfor-
mance. The types of product which are being smoked (especially
high tar delivery products where deposits can cover all parts of
the robot which come into contact with smoke) and the cleaning
frequency of the VC 10 should also be monitored by Vitrocell
users. Collectively, this information may inform and guide future
users and not delimit them as they consider experimental design.
Another technical variable is the diameters of the different jets
on the dilution bar (Fig. 1c) and the combinations in which they
should be used. They are recommended by the supplier based on
airﬂow range: the 2.0 mm£ smoke jet with 1.0 mm£ air jets
are recommended for airﬂows equal to or greater than 1 L/min;
the 2.0 mm£ smoke jet with 0.8 mm£ air jets are recommended
only for airﬂows less than 1 L/min. In this study, the B machines
were ﬁtted with air jets according to the supplier’s original recom-
mendations. In the dilution bar of machines A1, C1 and D1, the two
1.0 mm£ diluting air jets were used for all airﬂows tested. This
was based on previously observed QCM data which suggested jet
diameter had made no difference to particle dose. Thus, we con-
ducted a comparison study of the jet combinations (in two
machines only, one of which is reported here) which showed there
was no difference in deposition if the 2.0 mm£ smoke jet and
1.0 mm£ airﬂow jets were installed for airﬂows less than 0.5 L/
min (p = 0.961) which is the supplier recommended lowest airﬂow.
At 0.25 L/min, there was a statistically signiﬁcant difference in
deposition when comparing the two previously described jet com-
binations (p = 0.001, as determined by one-way ANOVA (at 0.25 L/
min in laboratory D, n = 5/QCM position/jet combination) however
the data sets did overlap). When the recommended jet combina-
tion was used, the mean values were lower and so too were SDs
when compared to the other data. However, this low airﬂow
should still be used with caution. Thus for experimental simplicity,
the same smoke and air jet combination (2.0 mm£ and 1.0 mm£
respectively) were maintained for all airﬂows for machines A1, C1
and D1. We have noted that there was a difference in the jets used
between the B machines and the other VC 10s, but ultimately all
machines performed similarly (with the exception of three airﬂows
on machine C1) and collectively, R&r for the test system of all six
VC 10s, gave acceptable values. The effect of jet combination on
dose may require further investigation, but so far the results we
have seen (at least in these six machines and from this data) sug-
gest jet diameter does not play a signiﬁcant role in particle deposi-
tion in the supplier’s recommended range (i.e. when 0.25 L/min is
excluded).
Our study assessed inter-machine variability across six VC 10s
and inter-laboratory variability across four independent labs.
Gauge R&r assessment on the whole data package demonstrated
good results, indicative that the systems collectively were ﬁt for
purpose: reproducibility (between all six VC 10s) and repeatability
(error within an individual VC 10) accounted for 0.3% and 7.4%,
respectively, where total R&rwas 7.7%. The largest variation in this
study came from the machine in laboratory C (Figs. 3, 5b and 6a,
and Table 4.); thus there may be co-effects of different environ-
mental conditions, the control andmaintenance of such conditions,
operator, differing cigarette shipments or cigarette conditioning
that impacted the variability of the results. In this study, laborato-
ries A, B and D had better control over environmental conditions
where temperature and humidity were set and maintained at
20 ± 5 C and 55 ± 15% relative humidity. The VC 10 in laboratoryC was placed inside an open cabinet, sat within a test room with
uncontrolled environmental conditions; additionally the cigarettes
were not conditioned for C1 data. Therefore it is likely that external
and laboratory environment contributed to the difference in
results observed from machine C1 when it was moved from an
uncontrolled environment (laboratory C) to a controlled one (labo-
ratory B) (Fig. 6a). On the other hand, during data collection in lab-
oratory D the humidity reached up to 72% (note that ISO
requirements specify humidity of 60 ± 5%) due to the ventilation
system connecting directly with the external environment and
yet this did not appear to affect the data, which were aligned with
the other machines and with small SDs (Table 3). This further high-
lights the requirement for users to characterise and understand
each individual VC 10 within its own environment, and to be aware
of important issues such as usage and machine cleanliness. It
would not be prudent to advise a service requirement for an indi-
vidual machine based on this data alone; clearly this would be
linked to each VC 10’s speciﬁc usage. At the very least an annual
service is required, while more frequent/daily use may require ser-
vice at shorter intervals (e.g. every 6 months).5. Conclusions
The results presented in this study demonstrate that the Vitro-
cell system is ﬁt for its intended purpose, when particle deposi-
tion is assessed collectively using QCMs. This study has
highlighted some slight differences between VC 10 machines in
terms of dilution and particle deposition gradients, which serves
as a foundation for understanding the working limits of the system.
At present it is unclear why some VC 10s observe a concentration
gradient and some do not, but what is clear is that this gradient is
more pronounced at higher smoke concentrations/lower diluting
airﬂows, especially 0.25 and 0.5 L/min. This observation may sug-
gest that there are technical challenges with turbulent mixing or
with the aerosol dynamics in the dilution system at the lower air-
ﬂow rates. This does not mean that these airﬂows should be
avoided; instead it could suggest a recommendation that biological
data at these airﬂows should be carefully considered in cases
where the lower airﬂow doses are having an effect on the biologi-
cal response.
QCMs are proving to be effective tools in the determination of
tobacco smoke particle dose in vitro. However, QCMs are only
one dosimetry tool and others have been investigated. These
include, but are not limited to: deposition quantiﬁcation using
chemical spectroﬂuorescence (Adamson et al., 2012); particle
number, size and surface area determination using differential
mobility spectrometry (Adamson et al., 2011); CO analysis
(Thorne et al., 2013); and vapour phase assessment of compounds
using a headspace stir bar-sorptive extraction technique (Kaur
et al., 2011). The investigation of these and additional tools to qual-
ify and quantify smoke dose remains an active area of research.
QCMs determine deposition in real-time and with precision (Paur
et al., 2011; Lenz et al., 2009), enabling the user to see puff-by-puff
and cigarette-by-cigarette proﬁles (Adamson et al., 2012). Addi-
tionally, QCMs are being used concurrently with biological expo-
sures and are proving beneﬁcial as a quality control tool (Thorne
et al., 2013). The QCM technology can be operated single-handedly
and requires little or no analytical resource when used for simple
quantiﬁcation alone. Furthermore, there is scope to use microbal-
ance technology for other engineered liquid droplet aerosols, aid-
ing inhalation toxicologists in other ﬁelds. For in vitro
applications, the microbalance technology can effectively discrim-
inate between high (9.4 mg) and low (1 mg) tar delivery products,
showing aligned results with traditional chemical methods of par-
ticle quantiﬁcation (Adamson et al., 2012). The tool has also
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effect of varying sample ﬂow rate applied to the module on particle
deposition, where this information was previously unknown/
assumed (Adamson et al., 2013).
In terms of the Vitrocell VC 10 Smoking Robot itself, this study
has clearly demonstrated the importance of variables which may
affect dose, and these should be assessed and monitored by users
of the VC 10. Primarily, our results suggest the environmental con-
ditions of the laboratory and machine service status may play an
important role in acquiring robust and repeatable QCM data over
time. Dilution bar jet diameter (smoke and air jets) appears to have
no effect on QCM determined particle deposition (based on this
data) but may need further investigation by individual users.
In summary, all of these additional factors aside, the dose–
responses obtained from all machines across the four different
locations demonstrated excellent agreement with Guage R&r for
the entire test system of 7.7%, being considered statistically ﬁt
for purpose.
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